Skip to main content
Erschienen in: European Surgery 1/2014

01.02.2014 | Review

Radiofrequency-based treatments for esophageal disease

verfasst von: C. R. Subramanian, G. Triadafilopoulos, MD, DSc

Erschienen in: European Surgery | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Summary

Background

Gastroesophageal reflux disease and its complication, Barrett’s esophagus, are two modern Western epidemics, and they are managed by a combination of medical and surgical approaches. Two new radiofrequency-based endoscopic methods, Stretta and HALO, have been introduced recently, and they are aiming at altering the compliance of the gastroesophageal junction and ablating the Barrett’s metaplastic mucosa, respectively.

Methods

We reviewed PubMed for all studies pertaining to Stretta and HALO technologies and collected data on techniques, clinical efficacy, safety, tolerability, and durability of effect.

Results

Although limitations exist, the safety, efficacy, tolerability, and durability of endoscopic radiofrequency energy application are robust and poised to facilitate the nonsurgical management of gastroesophageal reflux disease (GERD) and Barrett’s esophagus.

Conclusions

Over the past decade, Stretta and HALO have become valuable options in the current algorithms of management of refractory GERD and Barrett’s esophagus. Ongoing vigilance on the long-term benefits of radiofrequency and its effect on esophageal structure and function will allow even wider and more successful applications.
Literatur
1.
Zurück zum Zitat Tam WC, Schoeman MN, Zhang Q, Dent J, Rigda R, Utley D, Holloway RH. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut. 2003 Apr;52(4):479–85. PubMedCrossRef Tam WC, Schoeman MN, Zhang Q, Dent J, Rigda R, Utley D, Holloway RH. Delivery of radiofrequency energy to the lower oesophageal sphincter and gastric cardia inhibits transient lower oesophageal sphincter relaxations and gastro-oesophageal reflux in patients with reflux disease. Gut. 2003 Apr;52(4):479–85. PubMedCrossRef
2.
Zurück zum Zitat Triadafilopoulos G. Changes in GERD symptom scores correlate with improvement in esophageal acid exposure after the Stretta procedure. Surg Endosc. 2004 Jul;18(7):1038–44. PubMedCrossRef Triadafilopoulos G. Changes in GERD symptom scores correlate with improvement in esophageal acid exposure after the Stretta procedure. Surg Endosc. 2004 Jul;18(7):1038–44. PubMedCrossRef
3.
Zurück zum Zitat Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012 Feb;107(2):222–30. doi:10.1038/ajg.2011.395. PubMedCrossRef Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012 Feb;107(2):222–30. doi:10.1038/ajg.2011.395. PubMedCrossRef
4.
Zurück zum Zitat Noar MD, Noar E. Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction. Surg Endosc. 2008 Nov;22(11):2440–4. doi:10.1007/s00464-008-9873-4. PubMedCrossRef Noar MD, Noar E. Gastroparesis associated with gastroesophageal reflux disease and corresponding reflux symptoms may be corrected by radiofrequency ablation of the cardia and esophagogastric junction. Surg Endosc. 2008 Nov;22(11):2440–4. doi:10.1007/s00464-008-9873-4. PubMedCrossRef
5.
Zurück zum Zitat Kahrilas PJ, Howden CW, Wernersson B, Denison H, Nuevo J, Gisbert JP. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study. Aliment Pharmacol Ther. 2013 May;37(10):1005–10. doi:10.1111/apt.12298. PubMedCrossRef Kahrilas PJ, Howden CW, Wernersson B, Denison H, Nuevo J, Gisbert JP. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study. Aliment Pharmacol Ther. 2013 May;37(10):1005–10. doi:10.1111/apt.12298. PubMedCrossRef
6.
Zurück zum Zitat Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2012 Jun;10(6):612–9. doi:10.1016/j.cgh.2012.01.022. PubMedCrossRef Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW. Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2012 Jun;10(6):612–9. doi:10.1016/j.cgh.2012.01.022. PubMedCrossRef
7.
Zurück zum Zitat Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy. Gut. 2013 Jul 5. PMID: 23831734. (Epub ahead of print). Kahrilas PJ, Jonsson A, Denison H, Wernersson B, Hughes N, Howden CW. Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy. Gut. 2013 Jul 5. PMID: 23831734. (Epub ahead of print).
8.
Zurück zum Zitat Singh M, Gupta N, Gaddam S, Balasubramanian G, Wani S. Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett’s esophagus. Gastrointest Endosc. 2013 Nov;78(5):689–95. doi:10.1016/j.gie.2013.05.002. PubMedCrossRef Singh M, Gupta N, Gaddam S, Balasubramanian G, Wani S. Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett’s esophagus. Gastrointest Endosc. 2013 Nov;78(5):689–95. doi:10.1016/j.gie.2013.05.002. PubMedCrossRef
9.
Zurück zum Zitat Stolte M, Benicke J. Barrett’s Adenocarcinomas are frequently underdiagnosed as “high grade intraepithelial neoplasia”. Z Gastroenterol. 2012 Mar;50(3):273–8. doi:10.1055/s-0031-1281632. PubMedCrossRef Stolte M, Benicke J. Barrett’s Adenocarcinomas are frequently underdiagnosed as “high grade intraepithelial neoplasia”. Z Gastroenterol. 2012 Mar;50(3):273–8. doi:10.1055/s-0031-1281632. PubMedCrossRef
10.
Zurück zum Zitat Crockett SD, Lippmann QK, Dellon ES, Shaheen NJ. Health-related quality of life in patients with Barrett’s esophagus: a systematic review. Clin Gastroenterol Hepatol. 2009 Jun;7(6):613–23. doi:10.1016/j.cgh.2009.02.024. PubMedCentralPubMedCrossRef Crockett SD, Lippmann QK, Dellon ES, Shaheen NJ. Health-related quality of life in patients with Barrett’s esophagus: a systematic review. Clin Gastroenterol Hepatol. 2009 Jun;7(6):613–23. doi:10.1016/j.cgh.2009.02.024. PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Inadomi JM Surveillance in Barrett’s esophagus: a failed premise. Keio J Med. 2009 Mar;58(1):12–8. Inadomi JM Surveillance in Barrett’s esophagus: a failed premise. Keio J Med. 2009 Mar;58(1):12–8.
12.
Zurück zum Zitat Odze RD, Lauwers GY. Histopathology of Barrett’s esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy. 2008 Dec;40(12):1008–15. doi:10.1055/s-0028-1103416. PubMedCrossRef Odze RD, Lauwers GY. Histopathology of Barrett’s esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy. 2008 Dec;40(12):1008–15. doi:10.1055/s-0028-1103416. PubMedCrossRef
13.
Zurück zum Zitat Shaheen NJ, Peery AF, Hawes RH, Rothstein RI, Spechler SJ, et al. Quality of life following radiofrequency ablation of dysplastic Barrett’s esophagus. Endoscopy. 2010 Oct;42(10):790–9. doi:10.1055/s-0030-1255780. PubMedCentralPubMedCrossRef Shaheen NJ, Peery AF, Hawes RH, Rothstein RI, Spechler SJ, et al. Quality of life following radiofrequency ablation of dysplastic Barrett’s esophagus. Endoscopy. 2010 Oct;42(10):790–9. doi:10.1055/s-0030-1255780. PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002 Feb;55(2):149–56. Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH, et al. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002 Feb;55(2):149–56.
15.
Zurück zum Zitat Corley DA, Katz P, Wo JM, Stefan A, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003 Sep;125(3):668–76. Corley DA, Katz P, Wo JM, Stefan A, et al. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003 Sep;125(3):668–76.
16.
Zurück zum Zitat Aziz AM, El-Khayat HR, Sadek A, Mattar SG, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010 Apr;24(4):818–25. doi:10.1007/s00464-009-0671-4. Aziz AM, El-Khayat HR, Sadek A, Mattar SG, et al. A prospective randomized trial of sham, single-dose Stretta, and double-dose Stretta for the treatment of gastroesophageal reflux disease. Surg Endosc. 2010 Apr;24(4):818–25. doi:10.1007/s00464-009-0671-4.
17.
Zurück zum Zitat Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012 Aug;22(4):283–8. doi:10.1097/SLE.0b013e3182582e92. PubMedCrossRef Perry KA, Banerjee A, Melvin WS. Radiofrequency energy delivery to the lower esophageal sphincter reduces esophageal acid exposure and improves GERD symptoms: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2012 Aug;22(4):283–8. doi:10.1097/SLE.0b013e3182582e92. PubMedCrossRef
18.
Zurück zum Zitat Liu HF, Zhang JG, Li J, Chen XG, Wang WA. Improvement of clinical parameters in patients with gastroesophageal reflux disease after radiofrequency energy delivery. World J Gastroenterol. 2011 Oct 21;17(39):4429–33. doi:10.3748/wjg.v17.i39.4429. PubMedCrossRef Liu HF, Zhang JG, Li J, Chen XG, Wang WA. Improvement of clinical parameters in patients with gastroesophageal reflux disease after radiofrequency energy delivery. World J Gastroenterol. 2011 Oct 21;17(39):4429–33. doi:10.3748/wjg.v17.i39.4429. PubMedCrossRef
19.
Zurück zum Zitat Sharma VK, Wang KK, Overholt BF, Lightdale CJ, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007 Feb;65(2):185–95. Sharma VK, Wang KK, Overholt BF, Lightdale CJ, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett’s esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007 Feb;65(2):185–95.
20.
Zurück zum Zitat Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008 Nov;68(5):867–76. doi:10.1016/j.gie.2008.03.008. PubMedCrossRef Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008 Nov;68(5):867–76. doi:10.1016/j.gie.2008.03.008. PubMedCrossRef
21.
Zurück zum Zitat Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010 Oct;42(10):781–9. Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic radiofrequency ablation for Barrett’s esophagus: 5-year outcomes from a prospective multicenter trial. Endoscopy. 2010 Oct;42(10):781–9.
22.
Zurück zum Zitat Avilés A, Reymunde A, Santiago N. Balloon-based electrode for the ablation of non-dysplastic Barrett’s esophagus: ablation of intestinal metaplasia (AIM II Trial). Bol Asoc Med P R. 2006 Oct–Dec;98(4):270–5. Avilés A, Reymunde A, Santiago N. Balloon-based electrode for the ablation of non-dysplastic Barrett’s esophagus: ablation of intestinal metaplasia (AIM II Trial). Bol Asoc Med P R. 2006 Oct–Dec;98(4):270–5.
23.
Zurück zum Zitat Lyday WD, Corbett FS, Kuperman DA, et al. Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010 Apr;42(4):272–8. Lyday WD, Corbett FS, Kuperman DA, et al. Radiofrequency ablation of Barrett’s esophagus: outcomes of 429 patients from a multicenter community practice registry. Endoscopy. 2010 Apr;42(4):272–8.
24.
Zurück zum Zitat Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009 May 28;360(22):2277–88. Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009 May 28;360(22):2277–88.
25.
Zurück zum Zitat Sharma VK, Jae Kim H, Das A, Wells CD, et al. Circumferential and focal ablation of Barrett’s esophagus containing dysplasia. Am J Gastroenterol. 2009 Feb;104(2):310–7. Sharma VK, Jae Kim H, Das A, Wells CD, et al. Circumferential and focal ablation of Barrett’s esophagus containing dysplasia. Am J Gastroenterol. 2009 Feb;104(2):310–7.
26.
Zurück zum Zitat Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008 May;40(5):370–9. Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008 May;40(5):370–9.
27.
Zurück zum Zitat Ganz RA, Overholt BF, Sharma VK, Fleischer DE, et al. Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc. 2008 Jul;68(1):35–40. doi:10.1016/j.gie.2007.12.015. PubMedCrossRef Ganz RA, Overholt BF, Sharma VK, Fleischer DE, et al. Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc. 2008 Jul;68(1):35–40. doi:10.1016/j.gie.2007.12.015. PubMedCrossRef
28.
Zurück zum Zitat Torquati A, Houston HL, Kaiser J, et al Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease. Surg Endosc. 2004 Oct;18(10):1475–9. Torquati A, Houston HL, Kaiser J, et al Long-term follow-up study of the Stretta procedure for the treatment of gastroesophageal reflux disease. Surg Endosc. 2004 Oct;18(10):1475–9.
29.
Zurück zum Zitat Noar MD, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure. Gastrointest Endosc. 2007 Mar;65(3):367–72. Noar MD, Lotfi-Emran S. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure. Gastrointest Endosc. 2007 Mar;65(3):367–72.
30.
Zurück zum Zitat Wolfsen HC, Richards WO. The Stretta procedure for the treatment of GERD: a registry of 558 patients. J Laparoendosc Adv Surg Tech A. 2002 Dec;12(6):395–402. Wolfsen HC, Richards WO. The Stretta procedure for the treatment of GERD: a registry of 558 patients. J Laparoendosc Adv Surg Tech A. 2002 Dec;12(6):395–402.
31.
Zurück zum Zitat Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology. 2011 Aug;141(2):460–8. Shaheen NJ, Overholt BF, Sampliner RE, Wolfsen HC, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology. 2011 Aug;141(2):460–8.
32.
Zurück zum Zitat Orman ES, Kim HP, Bulsiewicz WJ, et al. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett’s esophagus with radiofrequency ablation. Am J Gastroenterol. 2013 Feb;108(2):187–95; quiz 196. doi:10.1038/ajg.2012.413. Orman ES, Kim HP, Bulsiewicz WJ, et al. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett’s esophagus with radiofrequency ablation. Am J Gastroenterol. 2013 Feb;108(2):187–95; quiz 196. doi:10.1038/ajg.2012.413.
33.
Zurück zum Zitat Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013 Oct;11(10):1245–55. doi:10.1016/j.cgh.2013.03.039. PubMedCrossRef Orman ES, Li N, Shaheen NJ. Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2013 Oct;11(10):1245–55. doi:10.1016/j.cgh.2013.03.039. PubMedCrossRef
34.
Zurück zum Zitat Triadafilopoulos G, Dibaise JK, Nostrant TT, et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc. 2001 Apr;53(4):407–15. Triadafilopoulos G, Dibaise JK, Nostrant TT, et al. Radiofrequency energy delivery to the gastroesophageal junction for the treatment of GERD. Gastrointest Endosc. 2001 Apr;53(4):407–15.
35.
Zurück zum Zitat Houston H, Khaitan L, Holzman M, Richards WO. First year experience of patients undergoing the Stretta procedure. Surg Endosc. 2003 Mar;17(3):401–4. Houston H, Khaitan L, Holzman M, Richards WO. First year experience of patients undergoing the Stretta procedure. Surg Endosc. 2003 Mar;17(3):401–4.
36.
Zurück zum Zitat Sharma VK, Kim HJ, Das A, et al. A prospective pilot trial of ablation of Barrett’s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 2008 May;40(5):380–7. doi:10.1055/s-2007-995587. PubMedCrossRef Sharma VK, Kim HJ, Das A, et al. A prospective pilot trial of ablation of Barrett’s esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 2008 May;40(5):380–7. doi:10.1055/s-2007-995587. PubMedCrossRef
37.
Zurück zum Zitat Peery AF, Shaheen NJ. Esophagus: endoscopic therapy for flat, dysplastic Barrett esophagus. Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):186–7. doi:10.1038/nrgastro.2011.38. PubMedCentralPubMedCrossRef Peery AF, Shaheen NJ. Esophagus: endoscopic therapy for flat, dysplastic Barrett esophagus. Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):186–7. doi:10.1038/nrgastro.2011.38. PubMedCentralPubMedCrossRef
38.
Zurück zum Zitat Bulsiewicz WJ, Kim HP, Dellon ES, Cotton CC, et al. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett’s esophagus. Clin Gastroenterol Hepatol. 2013 Jun;11(6):636–42. doi:10.1016/j.cgh.2012.10.028. PubMedCrossRef Bulsiewicz WJ, Kim HP, Dellon ES, Cotton CC, et al. Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic Barrett’s esophagus. Clin Gastroenterol Hepatol. 2013 Jun;11(6):636–42. doi:10.1016/j.cgh.2012.10.028. PubMedCrossRef
39.
Zurück zum Zitat Korst RJ, Santana-Joseph S, Rutledge JR, et al. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett’s esophagus: a single-center, phase II clinical trial. J Thorac Cardiovasc Surg. 2011 Nov;142(5):1168–73. doi:10.1016/j.jtcvs.2011.07.037. PubMedCrossRef Korst RJ, Santana-Joseph S, Rutledge JR, et al. Effect of hiatal hernia size and columnar segment length on the success of radiofrequency ablation for Barrett’s esophagus: a single-center, phase II clinical trial. J Thorac Cardiovasc Surg. 2011 Nov;142(5):1168–73. doi:10.1016/j.jtcvs.2011.07.037. PubMedCrossRef
40.
Zurück zum Zitat Krishnan K, Pandolfino JE, Kahrilas PJ, et al. Increased risk for persistent intestinal metaplasia in patients with Barrett’s esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology. 2012 Sep;143(3):576–81. doi:10.1053/j.gastro.2012.05.005. PubMedCentralPubMedCrossRef Krishnan K, Pandolfino JE, Kahrilas PJ, et al. Increased risk for persistent intestinal metaplasia in patients with Barrett’s esophagus and uncontrolled reflux exposure before radiofrequency ablation. Gastroenterology. 2012 Sep;143(3):576–81. doi:10.1053/j.gastro.2012.05.005. PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat van Vilsteren FG, Alvarez Herrero L, Pouw RE, Schrijnders D, et al. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett’s esophagus with early neoplasia: a prospective multicenter study. Endoscopy. 2013 Jul;45(7):516–25. van Vilsteren FG, Alvarez Herrero L, Pouw RE, Schrijnders D, et al. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett’s esophagus with early neoplasia: a prospective multicenter study. Endoscopy. 2013 Jul;45(7):516–25.
42.
Zurück zum Zitat Vaccaro BJ, Gonzalez S, Poneros JM, Stevens PD, et al. Detection of intestinal metaplasia after successful eradication of Barrett’s Esophagus with radiofrequency ablation. Dig Dis Sci. 2011 Jul;56(7):1996–2000. doi:10.1007/s10620-011-1680-4. PubMedCentralPubMedCrossRef Vaccaro BJ, Gonzalez S, Poneros JM, Stevens PD, et al. Detection of intestinal metaplasia after successful eradication of Barrett’s Esophagus with radiofrequency ablation. Dig Dis Sci. 2011 Jul;56(7):1996–2000. doi:10.1007/s10620-011-1680-4. PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Odze RD, Lauwers GY. Histopathology of Barrett’s esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy. 2008 Dec;40(12):1008–15. doi:10.1055/s-0028-1103416. PubMedCrossRef Odze RD, Lauwers GY. Histopathology of Barrett’s esophagus after ablation and endoscopic mucosal resection therapy. Endoscopy. 2008 Dec;40(12):1008–15. doi:10.1055/s-0028-1103416. PubMedCrossRef
44.
Zurück zum Zitat Kim MP, Brown KN, Schwartz MR, Blackmon SH. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia. Innovations (Phila). 2013 Jan–Feb;8(1):17–22. Kim MP, Brown KN, Schwartz MR, Blackmon SH. Advanced esophageal cancer in patients who underwent radiofrequency ablation for barrett esophagus with high-grade dysplasia. Innovations (Phila). 2013 Jan–Feb;8(1):17–22.
45.
Zurück zum Zitat Gupta M, Iyer PG, Lutzke L, Gorospe EC, Abrams JA, et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US Multicenter Consortium. Gastroenterology. 2013 Jul;145(1):79–86. Gupta M, Iyer PG, Lutzke L, Gorospe EC, Abrams JA, et al. Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett’s esophagus: results from a US Multicenter Consortium. Gastroenterology. 2013 Jul;145(1):79–86.
46.
Zurück zum Zitat Korst RJ, Santana-Joseph S, Rutledge JR, Antler A, et al. Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett’s esophagus. J Thorac Cardiovasc Surg. 2013 Jun;145(6):1529–34. Korst RJ, Santana-Joseph S, Rutledge JR, Antler A, et al. Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett’s esophagus. J Thorac Cardiovasc Surg. 2013 Jun;145(6):1529–34.
47.
Zurück zum Zitat Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010 Jan;8(1):23–9. Pouw RE, Wirths K, Eisendrath P, Sondermeijer CM, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for barrett’s esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2010 Jan;8(1):23–9.
48.
Zurück zum Zitat Haidry RJ, Dunn JM, Butt MA, Burnell MG, Gupta A, et al. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology. 2013 Jul;145(1):87–95. Haidry RJ, Dunn JM, Butt MA, Burnell MG, Gupta A, et al. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett’s esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Gastroenterology. 2013 Jul;145(1):87–95.
49.
Zurück zum Zitat Okoro NI, Tomizawa Y, Dunagan KT, Lutzke LS, Wang KK, Prasad GA. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett’s esophagus. Clin Gastroenterol Hepatol. 2012 Feb;10(2):150–4. Okoro NI, Tomizawa Y, Dunagan KT, Lutzke LS, Wang KK, Prasad GA. Safety of prior endoscopic mucosal resection in patients receiving radiofrequency ablation of Barrett’s esophagus. Clin Gastroenterol Hepatol. 2012 Feb;10(2):150–4.
Metadaten
Titel
Radiofrequency-based treatments for esophageal disease
verfasst von
C. R. Subramanian
G. Triadafilopoulos, MD, DSc
Publikationsdatum
01.02.2014
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 1/2014
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-013-0243-7

Weitere Artikel der Ausgabe 1/2014

European Surgery 1/2014 Zur Ausgabe